ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2026
A Public Health Approach to Antimicrobial Stewardship in Long-term Care Facilities: A Multifaceted Program in Massachusetts.
Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
15 authors.
Funding
Abstract
backgroundBenchmarking is an effective strategy to improve antibiotic use but remains underutilized in long-term care (LTC). In 2018, the Massachusetts Department of Public Health, in partnership with Tufts Medical Center, launched the Antibiotic Start (AS) Reporting Program, a statewide initiative to monitor and improve antibiotic prescribing in LTC facilities through monthly reporting and feedback, alongside other stewardship interventions.
methodsLong-term care facilities voluntarily submitted monthly AS data through an online platform. AS rates were calculated as AS per 1000 resident-days. Quarterly benchmarking reports and educational activities (introduced in 2022), including LTC office hours webinars, were conducted to support interpretation and engagement. We conducted an interrupted time-series (ITS) analysis to assess changes in beta-lactam and fluoroquinolone prescribing from 2018 to 2024 and a stratified analysis comparing AS rates between facilities with and without honor roll recognition.
resultsA total of 217 LTC facilities submitted ≥1 month of AS data. The overall AS rate increased by 7%, from 7.22 to 7.70 per 1000 resident-days. Fluoroquinolone starts decreased by 36%, while beta-lactam starts increased by 26%. Interrupted time series analysis showed a significant rise in beta-lactam use following the October 2022 expansion of benchmarking reports and LTC office hours (P < .001). A subgroup analysis showed higher total and beta-lactam AS rates among honor roll facilities compared with nonrecognized facilities.
conclusionsThe Massachusetts AS Reporting Program demonstrates that sustained, data-driven public health-academic collaboration can advance antimicrobial stewardship in LTC. By combining benchmarking, feedback, education, and recognition, public health agencies can support stewardship engagement and promote sustainable improvement in antibiotic use across resource-limited settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.